6 Hepatology Headlines You Missed in March 2026

March brought a series of meaningful developments in hepatology, spanning regulatory milestones, emerging therapies, and evolving perspectives on liver disease risk and management. From the first approved treatment for cholestatic pruritus in primary biliary cholangitis (PBC) to ongoing efforts to improve viral hepatitis care, the month highlighted both progress and persistent challenges across the field.